BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Bally's
BALY
$658M
| $49.6M | ﹤0.01% |
2,507,885
+474,222
| +23% | +$12.3M |
|
2502
Design Therapeutics
DSGN
$876M
| $49.6M | ﹤0.01% |
3,539,936
+389,116
| +12% | +$5.26M |
|
2503
Metropolitan Bank Holding Corp
MCB
$1.15B
| $49.4M | ﹤0.01% |
712,085
+23,355
| +3% | +$1.93M |
|
2504
ACV Auctions
ACVA
$1.3B
| $49.3M | ﹤0.01% |
7,540,261
+5,671,569
| +304% | +$58.4M |
|
2505
Core & Main
CNM
$8.71B
| $49.2M | ﹤0.01% |
2,207,182
+58,733
| +3% | +$1.36M |
|
2506
Gorman-Rupp
GRC
$2.21B
| $49.2M | ﹤0.01% |
1,738,257
+23,979
| +1% | +$746K |
|
|
TRTX
2507
TPG RE Finance Trust
TRTX
$618M
| $49.1M | ﹤0.01% |
5,444,065
+228,302
| +4% | +$2.39M |
|
|
PLYM
2508
DELISTED
Plymouth Industrial REIT
PLYM
| $49M | ﹤0.01% |
2,796,120
+288,311
| +11% | +$6.24M |
|
|
CPRX
2509
DELISTED
Catalyst Pharmaceutical
CPRX
| $48.7M | ﹤0.01% |
6,951,816
-490,793
| -7% | -$3.6M |
|
2510
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $48.7M | ﹤0.01% |
1,193,604
+13,759
| +1% | +$612K |
|
2511
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $48.7M | ﹤0.01% |
674,368
-28,703
| -4% | -$2.15M |
|
2512
Clearfield
CLFD
$374M
| $48.7M | ﹤0.01% |
785,563
-13,664
| -2% | -$802K |
|
|
TUP
2513
DELISTED
Tupperware Brands Corporation
TUP
| $48.6M | ﹤0.01% |
7,664,141
-274,065
| -3% | -$3.06M |
|
2514
Ferguson
FERG
$49.8B
| $48.6M | ﹤0.01% |
438,659
-5,852
| -1% | -$709K |
|
|
HAAC
2515
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $48.6M | ﹤0.01% |
4,914,296
| – | – |
|
2516
Warby Parker
WRBY
$3.25B
| $48.5M | ﹤0.01% |
4,310,025
+4,119,042
| +2,157% | +$82.8M |
|
|
GOOD
2517
Gladstone Commercial Corp
GOOD
$627M
| $48.4M | ﹤0.01% |
2,568,904
-69,064
| -3% | -$1.4M |
|
|
ACRE
2518
Ares Commercial Real Estate
ACRE
$270M
| $48.4M | ﹤0.01% |
3,955,431
-263,634
| -6% | -$3.83M |
|
2519
HUTCHMED
HCM
$2.17B
| $48.3M | ﹤0.01% |
3,822,367
+305,782
| +9% | +$3.89M |
|
2520
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $48.2M | ﹤0.01% |
602,464
+388,719
| +182% | +$31.7M |
|
2521
PureCycle Technologies
PCT
$1.45B
| $48.1M | ﹤0.01% |
6,487,920
+2,682,370
| +70% | +$22.5M |
|
2522
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $48.1M | ﹤0.01% |
1,306,788
-23,911
| -2% | -$947K |
|
2523
Outset Medical
OM
$90.8M
| $48M | ﹤0.01% |
215,544
-58,783
| -21% | -$25.3M |
|
2524
Accel Entertainment
ACEL
$987M
| $48M | ﹤0.01% |
4,518,544
+74,583
| +2% | +$834K |
|
|
FORG
2525
DELISTED
ForgeRock, Inc.
FORG
| $48M | ﹤0.01% |
2,239,566
+1,706,485
| +320% | +$33.5M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,354 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.